Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
The New York Times15h
World News
With a full-blown land war in Ukraine and an isolationist American president back in the White House, European leaders have come to a stark conclusion: They must spend more on their militaries ...
The New York Times18h
New York Times - Top Stories
Trump’s Moves to Upend Federal Bureaucracy Touch Off Fear and Confusion Agencies are gripped with uncertainty about how to implement a blizzard of President Trump’s new policies as workers ...